SELLAS Life Sciences SLS
NASDAQ SLS
$11.33 -0.98 (-7.96%)
At close: Oct 1, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Amortization - Intangibles (2013 - 2015)

Updated

SELLAS Life Sciences' Amortization - Intangibles was $1.88 million in FY2017.

Analysis

SELLAS Life Sciences (SLS) Amortization - Intangibles (2013 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 SELLAS Life Sciences 2.49 Bn 2.49 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 442,000.00
Mar 31, 2015 146,000.00
Sep 30, 2014 70,000.00
Jun 30, 2014 98,000.00
Mar 31, 2014 91,000.00
Sep 30, 2013 43,000.00
API Access

SELLAS Life Sciences Amortization - Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=SLS&period=max&api_key=YOUR_API_KEY